# Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease

> **NCT06430450** · — · NOT_YET_RECRUITING · sponsor: **Karamanoğlu Mehmetbey University** · enrollment: 80 (estimated)

## Conditions studied

- Periodontitis
- Periodontal Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Clinical measurements and saliva samples collection

## Key facts

- **NCT ID:** NCT06430450
- **Lead sponsor:** Karamanoğlu Mehmetbey University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2024-11-15
- **Final completion:** 2025-01-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430450, "Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06430450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*